The effects of total flavonoids from buckwheat flowers and leaves on renal damage and PTP1B expression in type 2 diabetic rats

Iranian Journal of Pharmaceutical Research

Volumn 10, Issue 3, 2011, Pages 511-517

  Chu, Jin Xiu ^a   Wang, Zhi Lu ^b   Han, Shu Ying ^a  

^a NORTH CHINA COAL MEDICAL COLLEGE   (China)

^b TANGSHAN TEACHERS COLLEGE   (China)

Author keywords

Buckwheat; Flavonoids; PTP1B; Renal damage; Type 2 diabetes mellitus

Indexed keywords

BENAZEPRIL; BUCKWHEAT EXTRACT; CREATININE; FLAVONOID; GLUCOSE; INSULIN; PLANT EXTRACT; PROTEIN TYROSINE PHOSPHATASE 1B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BUCKWHEAT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DOWN REGULATION; FLOWER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY INJURY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLANT LEAF; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; TREATMENT DURATION;

EID: 84863062790     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Han SY, Chen XY, Wang ZL, Liu SM, Zhu LS, Chu JX and Xin N. Inhibitory effect of total flavones of buckwheat flower on the non-enzymatic glycation of protein in-vivo and vitro. Chinese Pharmacological Bulletin (2004) 20: 1242-4.
2. Han SY, Zhang BZ, Zhu LS, Liu SM, Lv H, La WY, Shi J and Liang YP. Protective effect of total flavones of buckwheat flower on II diabetic and hyperlipidemia in rats. Chinese Pharmacological Bulletin (2003) 19: 477-9.
3. Han SY, Wang ZL, Zhu LS, Liu SM, Lv H and Chu JX. Study on the extraction technology of total flavonoids from buckwheat flowers and leaves. Chinese Traditional Patent Medicine (2005) 27: 730-1.
4. Ai J, Wang N, Du J, Yang M, Liu P, Du ZM and Yang BF. Establishment of type 2 diabetic animal model in Wistar rats. Chinese Pharmacological Bulletin (2004) 20: 1309-12.
5. Lee MK, Miles PD, Khoursheed M, Gao KM, Moossa AR and Olefsky JM. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes (1994) 43: 1435-9.
6. Niu FL, Chu JX and Han SY. Inhibitory effects of total flavones of buckwheat flower on the non-enzymatic glycation of proteins in-vivo and in-vitro. Chinese Journal of Clinical Rehabilitation. (2006) 10: 210-3.
7. Li GW and Pan XR. A new insulin-sensitivity index for the population-based study. Zhonghua Nei Ke Za Zhi (1993) 32: 656-60.
8. Bianchi S, Bigazzi R and Campese VM. Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications. Am. J. Kidney Dis. (1999) 34: 973-95.
9. Svensson M, Gustafsson F, Galatius S, Hildebrandt PR and Atar D. Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study. Br. Med. J. (2003) 15: 1141-2.
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. (1976) 72: 248-54.
11. th ed. Saunders, Philadelphia (2004) 2: 1777-818.
12. Sharma K and Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes (1995) 44: 1139-46.
13. Haj FG, Verveer PJ, Squire A, Neel BG and Bastiaens PIH. Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science (2002) 295: 1708-11.
14. Kasibhatla B, Wos J and Peters KG. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes. Curr. Opin. Investig. Drugs (2007) 8: 805-13.
15. Egawa K, Maegawa H, Shimizu S, Morino K, Nishio Y, Bryer-Ash M, Cheung AT, Kolls JK, Kikkawa R and Kashiwagi A. Protein tyrosine phosphatase-1B negatively regulates insulin signaling in L6 myocytes and Fao hepatoma cells. J. Biol. Chem. (2002) 276: 10207-11.
16. Wu XD, Hoffstedt J, Deeb W, Singh R, Sedkova N, Zilbering A, Zhu L, Park PK, Arner P and Goldstein BJ. Depot-specific variation in protein-tyrosine phosphatase activities in human mental and subcutaneous adipose tissue: a potential contribution to differential insulin sensitivity. J. Clin. EndocrinolMetab. (2001) 86: 5973-80.
17. Zhang J, Zhao CC, Han WN and Liu FZ. Effects of flavonoids on myocardial apoptosis. Chinese Pharmacological Bulletin (2008) 24: 635-9.
18. Yeh SL, Wang WY, Huang CH and Hu ML. Pro-oxidative effect of beta-carotene and the interaction with flavonoids on UVA-induced DNA strand breaks in mouse fibroblast C3H10T1/2 cells. J. Nutr. Biochem. (2005) 16: 729-35.
19. Cao WG, Liu ZQ, Shao Y and Tao YD. A progress in pharmacological research of flavonoids. Xibei Zhiwu Xuebao (2003) 25: 198-204.
20. Shaghaghi M, Manzoori J L, Afshar DJ and Jouyban A. Determination of flavonoids in pharmaceutical preparations using Terbium sensitized fluorescence method. Daru (2009) 17: 264-268.
21. Hooft-van-Huijsduijnen R, Sauer WHB, Bombrun A and Swinnen D. Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs. J. Med. Chem. (2004) 47: 4142-6.
22. Dixit M, Tripathi BK, Tamrakar AK, Srivastava AK, Kumar B and Goel A. Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors. Bioorg. Med. Chem. (2007) 15: 727-34.
23. Hansen SK, Cancilla MT, Shiau TP, Kung J, Chen T and Erlanson DA. Allosteric inhibion of PTP1B activity by selective modification of a non-active site cysteine residue. Biochemistry (2005) 44: 7704-12.